GW Pharmaceuticals Plc

... ...
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
VRXValeant Pharmaceuticals International, Inc. 1.28%27.0014.1%$158.87m
HZNPHorizon Therapeutics Plc 0.15%77.855.6%$141.18m
ACRSAclaris Therapeutics, Inc. -3.90%17.514.7%$134.11m
CTLTCatalent, Inc. -1.46%115.112.1%$102.90m
BHCBausch Health Cos., Inc. 1.28%27.000.0%$102.49m
JAZZJazz Pharmaceuticals Plc 1.46%171.112.4%$88.94m
UTHRUnited Therapeutics Corp. 0.06%167.8114.1%$61.02m
ISRIsoRay, Inc. -0.89%2.222.5%$60.19m
ACSTAcasti Pharma, Inc. -3.91%0.770.2%$60.10m
AMRNAmarin Corp. Plc 15.42%7.561.5%$58.61m
PRGOPerrigo Co. Plc 2.56%44.406.8%$51.95m
ARGXargenx SE 1.43%315.440.0%$51.23m
GWPHGW Pharmaceuticals Plc -0.11%141.556.1%$50.84m
SAVACassava Sciences, Inc. 17.33%15.100.0%$47.73m
TNXPTonix Pharmaceuticals Holding Corp. -0.97%1.020.2%$43.95m

Company Profile

GW Pharmaceuticals Plc is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It offers its cannabinoid product, Epidiolex oral solution CV, a pharmaceutical formulation of cannabidiol (CBD) focusing on the treatment of seizures associated with tuberous sclerosis complex. The company was founded by Geoffrey William Guy and Brian Whittle in 1998 and is headquartered in Cambridge, the United Kingdom.